1-3 of 3
Benjamin Thiele
Close
Sort by
Journal Articles

Opposite Effects of Bruton Tyrosine Kinase (BTK) Inhibitor Therapy with Ibrutinib and FCR Chemo-Immunotherapy on the Normal B Lymphocyte Repertoire in Patients with Chronic Lymphocytic Leukemia

Simon Schliffke, MD, Mariela Sivina, PhD, Ekaterina Kim, PhD, Benjamin Thiele, MD, Nuray Akyüz, PhD, Clemens Falker-Gieske, PhD, Toni Thenhausen, Artus Krohn-Grimberghe, PhD, Carsten Bokemeyer, MD, Nitin Jain, MD, Zeev Estrov, MD, Alessandra Ferrajoli, MD, William G. Wierda, MD PhD, Michael J. Keating, MD, Jan A. Burger, MD PhD, Mascha Binder, MD
Journal: Blood
Blood (2016) 128 (22): 4402.
https://doi.org/10.1182/blood.V128.22.4402.4402
Published: 2016
Journal Articles

A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma

Aneta Schieferdecker, Anna Oberle, Benjamin Thiele, Fabian Hofmann, Markus Göthel, Sebastian Miethe, Michael Hust, Friederike Braig, Mareike Voigt, Ute-Marie von Pein, Friedrich Koch-Nolte, Friedrich Haag, Malik Alawi, Daniela Indenbirken, Adam Grundhoff, Carsten Bokemeyer, Ulrike Bacher, Nicolaus Kröger, Mascha Binder
Journal: Blood
Blood (2016) 127 (25): 3202–3214.
https://doi.org/10.1182/blood-2015-10-676536
Published: 2016
Includes: Supplemental data
Journal Articles

Next-generation sequencing of peripheral B-lineage cells pinpoints the circulating clonotypic cell pool in multiple myeloma

Brief Report
Benjamin Thiele, Marie Kloster, Malik Alawi, Daniela Indenbirken, Martin Trepel, Adam Grundhoff, Mascha Binder
Journal: Blood
Blood (2014) 123 (23): 3618–3621.
https://doi.org/10.1182/blood-2014-02-556746
Published: 2014
Includes: Supplemental data